Li D M, Song J N, Yang Y, Jin L, Yang Y C, Zhang Z T
Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China.
Zhonghua Wai Ke Za Zhi. 2022 Jun 28;60(8):756-761. doi: 10.3760/cma.j.cn112139-20211008-00474.
To examine the prognosis factors for non-reversal of defunctioning ileostomy in rectal cancer surgery. The data of 234 patients with rectal cancer undergoing radical resection and defunctioning ileostomy in the Department of General Surgery, Beijing Friendship Hospital, Capital Medical University from January 2013 to June 2020 was analyzed retrospectively. There were 166 males and 68 females, aging (M(IQR)) 62(12) years (range: 33 to 89 years). Telephone following-up was conducted intensively in July 2021 to investigate whether stoma was reversed, causes of reversal failure, and tumor recurrence or metastasis after surgery. The non-reversal stoma was defined as stoma not being reversed during the follow-up period (more than 12 months). The χ test or Fisher's exact test was used to conduct a univariate analysis of clinical data related to reversal failure, and the factors with <0.05 were selected into Logistic regression for multivariate analysis. A total of 165 patients received stoma reversal postoperatively with an interval time of (6.5±2.4) months (range: 0.9 to 17.8 months), but 69 patients failed to closure of stoma. Univariate analysis showed that age, concomitant diseases, surgical methods, preoperative hemoglobin, preoperative carcinoembryonic antigen, tumor maximum diameter, depth of invasion, lymph node metastasis, TNM stage, anastomotic-related complications, postoperative tumor local recurrence or distant metastasis were associated with non-reversal of diverting ileostomy in rectal cancer surgery (all <0.05). Multivariate analysis showed that age (=2.270, 95%: 1.150 to 4.479, =0.018), open surgery (=7.249, 95%: 1.977 to 26.587, =0.003), preoperative hemoglobin<120 g/L (=3.092, 95%: 1.566 to 6.105, <0.01), anastomotic-related complications (=4.375, 95%: 1.686 to 11.349, =0.002), postoperative local recurrence or distant metastasis (=7.065, 95%: 2.591 to 19.264, <0.01) were independent prognosis factors for reversal failure of defunctioning stoma in rectal cancer surgery. There is a high risk of reversal failure of defunctioning ileostomy among rectal cancer patients with age>65 years, open surgery, preoperative hemoglobin<120 g/L, anastomotic-related complications, postoperative local recurrence or distant metastasis. Colorectal surgeons should fully evaluate the outcome and risk of reversal failure before making a decision of diverting ileostomy. Reducing anastomotic complications is helpful to the successful return of preventive ileostomy.
探讨直肠癌手术中回肠造口未回纳的预后因素。回顾性分析2013年1月至2020年6月首都医科大学附属北京友谊医院普通外科收治的234例行根治性切除及回肠造口术的直肠癌患者资料。其中男性166例,女性68例,年龄(中位数[四分位数间距])为62(12)岁(范围:33至89岁)。2021年7月进行电话随访,了解造口是否回纳、回纳失败原因及术后肿瘤复发或转移情况。未回纳造口定义为随访期间(超过12个月)造口未回纳。采用χ²检验或Fisher确切检验对与回纳失败相关的临床资料进行单因素分析,将P<0.05的因素纳入Logistic回归进行多因素分析。共有165例患者术后行造口回纳,间隔时间为(6.5±2.4)个月(范围:0.9至17.8个月),但69例患者造口未能关闭。单因素分析显示,年龄、合并症、手术方式、术前血红蛋白、术前癌胚抗原、肿瘤最大直径、浸润深度、淋巴结转移、TNM分期、吻合口相关并发症、术后肿瘤局部复发或远处转移与直肠癌手术中回肠造口未回纳有关(均P<0.05)。多因素分析显示,年龄(β=2.270,95%置信区间:1.150至4.479,P=0.018)、开放手术(β=7.249,95%置信区间:1.977至26.587,P=0.003)、术前血红蛋白<120 g/L(β=3.092,95%置信区间:1.566至6.105,P<0.01)、吻合口相关并发症(β=4.375,95%置信区间:1.686至11.349,P=0.002)、术后局部复发或远处转移(β=7.065,95%置信区间:2.591至19.264,P<0.01)是直肠癌手术中预防性造口回纳失败的独立预后因素。年龄>65岁、开放手术、术前血红蛋白<120 g/L、吻合口相关并发症、术后局部复发或远处转移的直肠癌患者回肠造口回纳失败风险较高。结直肠外科医生在决定行回肠造口术之前应充分评估回纳结果及失败风险。减少吻合口并发症有助于预防性回肠造口的成功回纳。